Effect of Blocking STAT3 Augments on Resistance of Human Prostate Cancer Cells to Docetaxel

Qifang ZHANG,Changxue WU,Zhizhong GUAN

DOI: https://doi.org/10.19367/j.cnki.1000-2707.2015.11.005

2015-01-01

Abstract:Objective: To investigate the effect of STAT3 silencing on the sensitivity of human prostate cancer cells to docetaxel treatment. Methods: Lentiviruses expressing STAT3-specific shRNA were used to infect human prostate cancer DU145 cells to generate a stable cell line as shRNA group,non-specific shRNA as mock group. STAT3 expression and Bcl-2 expression were detected by Western blot. Apoptosis induced by docetaxel was assessed by Annexin V / PI Staining. To determine the effect of STAT3 inhibition on anti-tumor effect of docetaxol in vivo,STAT3 shRNA plasmid and doectaxol were injected into subcutaneous DU145 tumors and perifeneals of NSG immunodeficient male mice,respecti-vely. Tumor weights and tumor volumes were examined at 22 d after implantation. Results:STAT3 expression was significantly silenced. STAT3 silencing resulted in the downregulation of its downstream target,an anti-apoptotic gene Bcl-2. The apoptotic cell death induced by docetaxel was significantly augmented by STAT3 inhibition and apoptotic cells had 4-fold increase compared mock group. Tumor formation assay showed that the tumor weight and tumor volumes in DOX + shRNA group were remarkably decreased when compared to mock + DOX group. The tumor inhibition was about80% in DOX + shRNA group. Conclusions: STAT3 silencing enhances the sensitivity of Du145 cells to docetaxel and antitumor effect of docetaxel.